2.2 Communicable Diseases & Dermatological Manifestations

Communicable Diseases & Dermatological Manifestations

Because Registered Massage Therapists maintain continuous, direct palpatory contact with the largest organ of the human body—the integumentary system—a comprehensive mastery of communicable dermatological pathologies is vital for patient safety and clinical decision-making. The skin serves as a primary physical and immunological barrier against external pathogens. When this barrier is breached or colonized by infectious agents, manual therapy can exacerbate tissue damage, promote systemic dissemination, or cross-contaminate the practitioner, other patients, and clinic equipment.

---

Clinical Classification of Contraindications

In Canadian manual therapy, pathological conditions are categorized into two primary clinical contraindication levels:

1. Absolute Contraindication: Systemic, widespread, or severe acute pathologies where no massage therapy may be performed anywhere on the body. Applying manual therapy would present an unacceptable risk of aggravating the condition, causing systemic embolization or bacteremia, or spreading highly contagious pathogens across the clinic environment. Examples include acute cellulitis, active widespread impetigo, acute systemic herpes zoster, and active scabies.
2. Local Contraindication: Well-circumscribed, non-spreading conditions where manual techniques are strictly avoided over the affected anatomical region and surrounding margins, while general massage therapy may safely proceed over uninvolved body areas. Examples include localized verruca vulgaris (warts), isolated minor folliculitis, or inactive healed tinea corporis well-controlled under medical care.

---

Bacterial Skin Infections

Bacterial infections of the skin primarily involve gram-positive pyogenic cocci, predominantly Staphylococcus aureus (including Methicillin-Resistant S. aureus [MRSA]) and Streptococcus pyogenes (Group A Streptococcus [GAS]).

Impetigo

• Etiology: Highly superficial, intra-epidermal infection caused by Staphylococcus aureus or Streptococcus pyogenes.
• Clinical Presentation: Primarily manifests as small, fragile vesicles or pustules that easily rupture, releasing a purulent exudate that desiccates into characteristic honey-colored ("stuck-on") crusts. Common predilection sites include the perioral and perinasal areas of the face, hands, and extremities. In bullous impetigo, larger, flaccid bullae form and leave red, raw erosions upon rupture.
• Contagiousness: Extremely high via direct skin-to-skin contact, fluid autoinoculation, and contaminated linens or toys.
• Clinical Decision & Contraindication Level: Absolute Contraindication if lesions are widespread, untreated, or weeping. If a patient presents with a single, small, discrete lesion that has been under effective antibiotic therapy and is completely dry and covered, some texts treat it as a strict local contraindication; many clinics prefer treatment deferral until resolution to eliminate clinic contamination risks.

Cellulitis

• Etiology: Acute, rapidly advancing bacterial infection extending deeply into the deep dermis and subcutaneous adipose tissue, most commonly caused by Streptococcus pyogenes or Staphylococcus aureus entering through a cutaneous break (e.g., crack, insect bite, athlete's foot, surgical puncture).
• Clinical Presentation: Characterized by the cardinal signs of acute inflammation: intense, poorly demarcated erythema (redness), pronounced local warmth, marked edema (swelling) with taut, glossy skin, and severe, throbbing pain. Borders are ill-defined and diffuse, rapidly advancing over hours. Systemic manifestations are frequent, including fever, chills, tachycardia, malaise, and regional lymphadenopathy. Red linear streaks extending proximally along lymphatic pathways indicate ascending lymphangitis.
• Clinical Decision & Contraindication Level: STRICT ABSOLUTE CONTRAINDICATION. Manual therapy over or near cellulitis risks driving bacteria into deep venous and lymphatic channels, leading to septicemia, necrotizing fasciitis, or thrombophlebitis. The therapist must immediately terminate the session, outline the advancing red border with a surgical pen if clinically appropriate, and direct the patient to an emergency department or urgent medical care.

Erysipelas

• Etiology: An acute superficial cutaneous variant of cellulitis predominantly caused by Group A beta-hemolytic Streptococcus, involving the upper dermis and superficial lymphatics.
• Clinical Presentation: Presents with an intense, fiery-red, shiny, indurated plaque characterized by sharply raised, clearly demarcated borders distinguishing it from normal skin. Most common on the lower extremities and face ("butterfly" distribution). Rapid onset accompanied by prominent fever, chills, and headache.
• Clinical Decision & Contraindication Level: STRICT ABSOLUTE CONTRAINDICATION. Requires urgent medical physician referral for systemic intravenous or oral antibiotic therapy.

Folliculitis, Furuncles, and Carbuncles

• Etiology: Suppurative bacterial inflammation centered on hair follicles, almost universally initiated by Staphylococcus aureus.
• Clinical Presentation:
  • Folliculitis: Superficial erythematous papules or tiny pustules pierced centrally by a hair shaft, commonly located on the beard area, buttocks, thighs, and back.
  • Furuncle (Boil): A deep, painful, firm inflammatory nodule developing from folliculitis that progresses to necrosis, central suppuration, and fluctuance.
  • Carbuncle: A coalescent cluster of multiple furuncles connected by subcutaneous sinus tracts, discharging pus through multiple follicular orifices, often accompanied by low-grade fever.
• Clinical Decision & Contraindication Level: Local Contraindication for isolated, mild, non-spreading folliculitis (avoid the anatomical region completely to prevent autoinoculation). Absolute Contraindication if lesions are multiple, coalescent (carbuncle), actively discharging purulent material, or accompanied by systemic malaise or fever.

---

Viral Skin Infections

Viral dermatological infections frequently establish long-term intracellular latency within neurological ganglia or epithelial cells, presenting episodic clinical reactivations.

Herpes Simplex Virus (HSV-1 and HSV-2)

• Pathogenesis: HSV-1 (predominantly orofacial) and HSV-2 (predominantly genital) invade epidermal cells and ascend via retrograde axoplasmic transport to reside latently within sensory nerve ganglia (trigeminal ganglion for HSV-1; sacral ganglia S2–S4 for HSV-2). Reactivation is triggered by immunosuppression, psychological stress, ultraviolet light exposure, hormonal shifts, or mechanical trauma.
• Clinical Presentation: A prodromal sensory phase of localized tingling, itching, or hyperesthesia (12–24 hours), followed by the emergence of tightly grouped, fluid-filled vesicles on an erythematous base ("dewdrops on a rose petal"). Vesicles rupture within 24 to 48 hours, exuding clear infectious viral serous fluid, then form golden crusts that heal without scarring over 7 to 10 days.
• Clinical Decision & Contraindication Level: Strict Local Contraindication during active vesicular, ulcerated, or crusting phases (avoid the face, lips, neck, or pelvic area completely). If the therapist develops a lesion on the hand—termed Herpetic Whitlow (HSV infection of the finger/nail bed)—the practitioner is strictly prohibited from providing direct patient care until the lesion is completely re-epithelialized and dry, as gloves do not eliminate viral shed risks.

Herpes Zoster (Shingles)

• Pathogenesis: Reactivation of latent Varicella-Zoster Virus (VZV) dormant in cranial nerve sensory ganglia or dorsal root ganglia following childhood chickenpox. Upon reactivation, the virus travels down the sensory nerve axon to the cutaneous dermatome.
• Clinical Presentation: Severe unilateral, radicular, neurogenic burning or stabbing pain, allodynia, and paresthesia localized strictly to a single unilateral dermatome (most commonly thoracic T3–L2, or ophthalmic branch of cranial nerve V). Within about 2 to 4 days, an intense erythematous maculopapular rash erupts along the dermatome, rapidly progressing to grouped vesicles that usually crust over within about 7 to 10 days; the rash typically heals in 2 to 4 weeks. Systemic malaise and low-grade fever are common.
• Contagiousness: The fluid within active vesicles contains live VZV, which can be transmitted to individuals who have not had chickenpox or the varicella vaccine, causing primary varicella.
• Clinical Decision & Contraindication Level: Absolute Contraindication during the acute eruptive and vesicular stage due to acute systemic viral activity, intense hyperpathia/allodynia, and viral transmission risk. Once all lesions are completely crusted and dry, massage may proceed; however, if the patient develops Post-Herpetic Neuralgia (PHN)—chronic intractable nerve pain persisting months or years after rash clearance—the affected dermatome remains a strict local contraindication to deep or vigorous pressure, requiring specialized, non-noxious neural desensitization techniques.

Warts (Verruca Vulgaris & Plantar Warts)

• Etiology: Benign epithelial proliferations induced by Human Papillomavirus (HPV), predominantly types 1, 2, 4, 27, and 57.
• Clinical Presentation: Verruca Vulgaris (Common Warts): Hyperkeratotic, exophytic, rough, flesh-colored papules displaying pinpoint black dots representing thrombosed dermal capillaries. Verruca Plantaris (Plantar Warts): Painful, flat, hyperkeratotic lesions on the weight-bearing plantar aspect of the foot that disrupt normal skin lines (striae).
• Contagiousness: Transmitted via direct skin contact or contaminated surfaces (clinic floors, shower tiles) through micro-fissures in the stratum corneum.
• Clinical Decision & Contraindication Level: Strict Local Contraindication. The therapist must avoid direct friction or manipulation over the lesion to prevent autoinoculation to surrounding skin. For plantar warts, avoid bare hand contact; if working near the region, use a barrier or glove, and perform intermediate-level disinfection on contaminated surfaces.

Molluscum Contagiosum

• Etiology: Cutaneous infection caused by a double-stranded DNA Poxvirus.
• Clinical Presentation: Multiple discrete, smooth, dome-shaped, firm, pearly papules displaying central umbilication (a tiny central depression). Lesions contain a curd-like, infectious caseous core containing virions. Commonly found on the trunk, axillae, inner thighs, and antecubital fossa.
• Clinical Decision & Contraindication Level: Local Contraindication. Avoid direct contact, petrissage, or friction over the papules. Mechanical pressure can express the central viral plug, causing autoinoculation across adjacent skin folds.

Fungal Infections (Mycoses & Dermatophytes)

Superficial fungal infections of the keratinized stratum corneum, hair, and nails are primarily caused by dermatophytes (genera Trichophyton, Microsporum, and Epidermophyton) that metabolize keratin, as well as lipophilic yeasts.

Tinea Infections (Dermatophytosis)

1. Tinea Corporis (Ringworm):
   • Presentation: Characterized by one or multiple annular (ring-shaped), erythematous scaly plaques displaying an elevated, active, advancing vesicular or papular border with central clearing (giving the classic ring appearance). Pruritus is common.
   • Transmission: Highly contagious via direct skin-to-skin contact, animal vectors (pets), contaminated linens, and upholstery.
   • Contraindication Level: Strict Local Contraindication. The affected area and a 5 cm surrounding margin must be completely avoided. The area must be draped with a clean barrier towel that is discarded directly into the laundry hamper immediately following the treatment.
2. Tinea Pedis ("Athlete's Foot"):
   • Presentation: Three distinct clinical patterns: 1) Interdigital (erythema, maceration, scaling, and painful fissuring in the toe web spaces, particularly between the 4th and 5th toes); 2) Moccasin distribution (diffuse, chronic, fine silvery scaling and hyperkeratosis along the soles and lateral foot margins); 3) Vesiculobullous (pruritic, painful vesicles on the sole/instep).
   • Contraindication Level: Local Contraindication. Manual therapy is omitted over the feet, or if treatment is clinically necessary, the therapist must wear medical examination gloves and ensure feet are draped. Barefoot walking in clinic spaces is prohibited.
3. Tinea Cruris ("Jock Itch"):
   • Presentation: Sharply marginated, crescent-shaped erythematous scaly rash with an active advancing edge located in the groin, crural folds, and inner upper thighs, typically sparing the scrotum.
   • Contraindication Level: Local Contraindication. Avoid the anatomical region completely.
4. Tinea Versicolor (Pityriasis Versicolor):
   • Etiology: Not a dermatophyte, but an opportunistic overgrowth of the commensal dimorphic yeast Malassezia globosa / furfur.
   • Presentation: Multiple circular or oval, finely scaling macules and patches located on the chest, back, neck, and proximal arms. Lesions appear hypopigmented (failing to tan in summer) or hyperpigmented (salmon or light brown) relative to adjacent skin.
   • Contraindication Level: Local Precaution / Modification. Tinea versicolor is essentially non-contagious under standard clinical conditions, as the organism is part of normal skin flora. However, therapists should avoid vigorous cross-fiber friction over extensively flaking areas to prevent epidermal irritation.

---

Parasitic Infestations

Parasitic skin infestations are caused by external ectoparasites that colonize human hair, stratum corneum, or clothing, creating extreme pruritus and widespread transmission risks.

Scabies

• Etiology: Infestation by the microscopic human itch mite, Sarcoptes scabiei var. hominis. The fertilized adult female mite burrows into the stratum corneum, depositing eggs and feces (scybala).
• Clinical Presentation:
  • Intense, debilitating pruritus, classically exacerbated at night when mites become active.
  • Burrows: Pathognomonic thin, serpiginous, wavy, slightly elevated grayish-white or brown thread-like tracks (2 to 10 mm in length), often ending in a tiny vesicle.
  • Predilection Sites: Interdigital web spaces of the fingers, anterior flexor surfaces of the wrists, elbows, axillary folds, umbilicus, waistline, buttocks, genitalia, and inframammary folds.
  • Secondary lesions: Excoriations, crusted papules, and secondary bacterial infections (impetiginization) resulting from chronic scratching.
• Contagiousness: Extremely high through prolonged, direct skin-to-skin contact, as well as shared linens, bedding, towels, and furniture.
• Clinical Decision & Contraindication Level: STRICT ABSOLUTE CONTRAINDICATION. No massage therapy may be conducted until the patient has completed the prescribed scabicide treatment (e.g., topical 5% permethrin, often repeated after 7 to 14 days, or oral ivermectin) and the infestation has been confirmed as cleared. If a patient with active scabies inadvertently enters the clinic, the treatment room, table, linens, and clothing must undergo extensive high-temperature laundering and intermediate-level chemical decontamination.

Pediculosis (Lice Infestation)

• Etiology: Infestation by human lice species: Pediculus humanus capitis (head lice), Pediculus humanus corporis (body lice), and Phthirus pubis ("crab" lice).
• Clinical Presentation: Intense itching; visualization of live crawling lice or tiny, oval, grayish-white nits (eggs) firmly cemented to the base of hair shafts within 6 mm of the scalp. Unlike dandruff, nits cannot be easily brushed or shaken off.
• Clinical Decision & Contraindication Level: STRICT ABSOLUTE CONTRAINDICATION. Therapy must be postponed until the infestation is completely eradicated, all nits are removed with specialized nit combs, and medical clearance is attained.

---

Recognizing Suspicious Pigmented Lesions & Cutaneous Malignancies

Registered Massage Therapists routinely observe areas of the patient's body that the patient rarely inspects, such as the posterior thorax, scapular regions, posterior thighs, and scalp. While RMTs are strictly prohibited from diagnosing cancer or pathology, they carry an ethical, professional, and regulatory duty to recognize suspicious dermatological abnormalities, document observations objectively, and initiate prompt medical physician referral.

Cutaneous Malignancies Overview

The ABCDE Criteria for Malignant Melanoma

The clinical benchmark for evaluating pigmented skin lesions is the ABCDE Framework:

• A — Asymmetry: One half of the mole or pigmented lesion does not match the other half in shape, contour, or thickness.
• B — Border Irregularity: The edges of the lesion are scalloped, ragged, notched, blurred, or poorly defined, fading indistinctly into adjacent normal epidermis.
• C — Color Variegation: The color is not uniform across the lesion. Displays a mottled mixture of shades, including tan, dark brown, and jet black, or suspicious hues of red, white, or slate-blue.
• D — Diameter: The diameter exceeds 6 millimeters (approximately the size of a standard pencil eraser), although early invasive melanomas can be smaller.
• E — Evolving: The lesion is actively changing over time in size, shape, surface elevation, color, or displays new symptoms such as persistent itching, spontaneous bleeding, oozing, or ulceration. (The "Ugly Duckling" sign—a lesion that looks distinctly different from all other moles on the patient's body—is an equally vital red flag).

Clinical Management & Professional Scope of Practice

When a therapist observes a lesion exhibiting one or more ABCDE criteria or signs of non-melanoma carcinoma:

1. Strictly Avoid Mechanical Friction: Do not apply compression, friction, petrissage, or stretching directly over the lesion (Local Contraindication), as mechanical shearing forces could cause microtrauma, ulceration, or promote local lymphatic dislodgement.
2. Objective Clinical Documentation: Record the precise anatomical location, approximate dimensions (measured with a paper ruler), shape, coloration, and border characteristics in the Objective section of the clinical health record.
3. Non-Alarmist Patient Communication: Inform the patient calmly: "During my assessment of your upper back, I noticed a pigmented mole that appears slightly uneven and darker on one side. Are you aware of this spot? Has a physician or dermatologist checked it recently? I strongly encourage you to have your family physician examine it to ensure it is healthy."
4. Physician Referral: Document the verbal referral in the treatment notes, providing the patient with objective details to share with their primary care provider.

---

Dermatological Conditions Summary Table